← Leaderboards
Jillian R Brown
Zacharon Pharmaceuticals, Inc.
$1,377,386
Attributed
$1,858,236
Total exposure
6
Grants
6
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants.
Funding over time
peak $500K · FY2008–25$500K$375K$250K$125K$0
'08
'09
'10
'11
'12
'13
'14
'15
'16
'17
'18
'19
'20
'21
'22
'23
'24
'25
Funding mix
By agency
NIH$1,858,236 · 6
By mechanism
R43$1,858,236 · 6
Top collaborators
- Charles Alexander Glass2 shared
Others in their field
Top investigators on “Symptoms”
- Randall J Bateman · Washington University$155,860,406
- Judith S Hochman · New York University School Of Medicine$111,581,511
- Jan C Buckner · Mayo Clinic Coll Of Medicine, Rochester$98,224,091
- Eric Martin McDade · Washington University$96,219,353
- Beth Baseler · Leidos Biomedical Research, Inc.$87,027,148
- Monica M Bertagnolli · Strang Cancer Prevention Center$85,994,687
Research focus
SymptomsMouse ModelPharmaceutical PreparationsBrainBlood - Brain Barrier AnatomyEnzymesMutationNerve DegenerationBypassAnimalsBiochemicalEnzyme Replacement TherapyBehavioral StudyCerebrospinal FluidLysosomal Storage DiseasesL-IduronidaseLysosomesMucopolysaccharidosesBiological MarkersBiodistributionHistologicInjectionsCellsCessation Of Life
Grant awards (6)
Title: New Clinical Biomarkers for GM1 Gamgliosidosis$500,000
R43 · FY2025 · NS · contact PI
Title: Development and Validation of Therapy for GM1 Gangliosidosis$461,701
R43 · FY2023 · NS · contact PI
Title: Intracerebroventricular sulfamidase delivery to the Brain$258,169
R43 · FY2020 · NS · contact PI
Intracerebroventricular alpha-N-acetylglucosaminidase Delivery to the Brain$225,254
R43 · FY2019 · NS · contact PI
Intracerebroventricular Iduronidase Delivery to the Brain$225,000
R43 · FY2018 · NS · contact PI
Structure-activity relationship study of an inhibitor of tumor metastasis$188,112
R43 · FY2008 · CA · contact PI